While a number of prostate cancer patients in New Zealand are given MRI scans as part of their diagnostic process, this is limited by both the availability of the high quality technology required, particularly in regional centres, and the limited access to MRI scanners in the public health system. Clearly this new Guidance issued by the UK’s NHS is an approach New Zealand should adopt.

Read the Telegraph’s story here